Should patients on bosentan have regular liver function checks?

Why do doctors order liver function tests for bosentan patients?

Bosentan blocks endothelin receptors and relaxes blood vessels, but it can raise liver enzymes in some patients. Early studies showed this occurred in about 11 percent of users, prompting the FDA to require monthly monitoring. Regular checks detect rises in ALT and AST before symptoms appear.

How often are tests recommended?

Doctors check liver enzymes before starting treatment, then monthly for the first four months. After that, they test quarterly if values stay normal. Any jump triggers more frequent testing until values stabilize.

What happens if liver enzymes rise?

Levels that verdopple oder vervierfachen the upper limit of normal lead doctors to reduce the dose or stop the drug. Severe elevations often require complete discontinuation. Recovery takes weeks once the drug is removed.

Can other drugs increase the risk?

Bosentan interacts with CYP3A4 inhibitors such as ketoconazole, itraconazole, and fluconazole. These compounds slow bosentan metabolism, pushing up levels and the risk of liver injury. Patients must tell their doctor every drug they take.

Does monitoring change after the drug has used for months?

Patients who pass the four-month mark with stable results switch to quarterly checks. However, clinicians still perform tests whenever new symptoms appear—fatigue, nausea, jaundice—or when new medications are added.

Are there biosimilars or generics that change monitoring rules?

No biosimilars exist for bosentan. Only generic versions of the branded product exist. The same liver-test schedule applies to both brand and generic.